MR
MariMed Inc.
MRMD · OTC
$0.07 -2.03% (-$0.00)
1M -5.06%
Market Cap $28.9M
P/E Ratio -
Div. Yield -
ROE 29.67%
Bulios Fair Price
$0.08
10.3% upside
Current Price
$0.073
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MRMD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
87 /100
Cheap P/S 0.18x
P/B 0.64x
P/FCF 3.51x
Growth
40 /100
Stable Book val. growth 4.11%
Rev. growth 6.05%
FCF growth N/A
Profitability
25 /100
Weak Net margin 9.13%
Op. margin 0.93%
FCF margin 5.04%
Quality
10 /100
Poor ROE 29.67%
ROA 7.58%
Asset turnover 0.83x
Debt
9 /100
High Current ratio 0.92x
Int. coverage -0.24x
Net debt/EBITDA 8.84x
Stability
42 /100
Moderate Rev. volatility 4.86%
EPS volatility 134.73%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jon R. Levine
Employees
866
Headquarters
Norwood
Upcoming events
04 NOV
Earnings
Upcoming earnings report